OVERVIEW

Breaking the Barriers: Improving Access to Biologic Therapies in IBD is organized by Gastrointestinal Health Foundation (GiHF) and will be held from Aug 02, 2018 - Aug 02, 2019.

Target Audience:
This webcast will target members of the health care team who navigate the prior authorization process and provide practical tools and strategies to minimize access barriers to biologic therapies in IBD.

Accreditation Statement:
ANCC Accreditation
A maximum of 0.5 contact hours may be earned for successful completion of this activity.

AANP Accreditation
This program is accredited for 0.5 contact hours. Program ID #5611.

AAPA Accreditation
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 CME credits. Approval is valid for one year from 08/02/2018. PAs should only claim credit commensurate with the extent of their participation.

Educational Objectives:
Upon completion of this activity, participants should be better able to:
• Describe the clinical rationale for biologic therapies in IBD and their potential for improving patient outcomes.
• Communicate effectively with payers regarding PA requirements for biologic therapies in IBD.
• Incorporate practical tools to reduce the prior authorization burden and facilitate timely approval of biologics in IBD.

Additional details will be posted as soon as they are available.